Gut microbiome data phase II PRIMMO trial
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
PRIMMO was a non-randomized, multisite, phase II trial that investigated a pembrolizumab-based regimen in patients with recurrent and/or metastatic cervical (CC) or endometrial (EC) carcinoma who had at least one prior line of systemic therapy. Gut microbiome data were collected and analyzed from 35 patients (79 samples).
创建时间：
2025-05-30
